Artificial intelligence is reshaping healthcare, but many organizations are still struggling to unlock its full potential. Success starts with people, processes, and strategy – not just technology.At HIMSS25 in Las Vegas, the AI in…
Continue Reading
Researchers at the University of Westminster have developed a chatbot for discussing sensitive topics, which they believe could help reduce health inequalities.
The study, published in the journal PLOS Digital Health on 13 February 2025,…
What You Should Know:
– Abridge, a provider of generative AI solutions for healthcare, today received the first annual Trailblazer award from the College of Healthcare Information Management Executives (CHIME) and KLAS Research.
– The prestigious…
Continue Reading
What You Should Know:
– Vitalchat, a provider of AI-powered ambient solutions for in-patient virtual nursing and procedural telehealth raises $6M in Series A funding led by Green Harvest Capital Industries (GHC Industries), with participation…
Continue Reading
Memorial Sloan Kettering Cancer Center is teaming up with AWS to accelerate its oncology research with AI, the health system announced Monday at the ViVE conference in Nashville.
By using AI to analyze vast amounts…
Continue Reading
What You Should Know:
– Abridge, a provider of generative AI solutions for healthcare, today announced a $250M Series D funding round, bringing its total capital raised to over $425M.
– The investment, co-led by Elad…
Continue Reading
As artificial intelligence has proliferated to all corners of the healthcare delivery system, it’s being embraced by more and more clinicians – albeit with a healthy degree of skepticism.One group of care providers who…
Continue Reading
Richard Schwabacher, SVP of Healthcare Product at Inmar Intelligence
Imagine refilling a prescription, getting real-time health advice, and managing chronic conditions — all with the help of AI. The future of healthcare is here, and…
Continue Reading
Primary cutaneous squamous cell carcinoma (cSCC) is responsible for ~10,000 deaths annually in the United States. Stratification of risk of poor outcome at initial biopsy would significantly impact clinical decision-making during the initial post…
Continue Reading
Proposed legislation introduced in the U.S. House of Representatives will allow AI and machine learning technology to prescribe drugs approved by the FDA autonomously. The bill, H.R.238, introduced on Jan. 7, would require amending the…
Continue Reading
